An Opposing View on WWOX Protein Function as a Tumor Suppressor

Cancer Research

Volumn 63, Issue 24, 2003, Pages 8629-8633

  Watanabe, Akira ^a   Hippo, Yoshitaka ^a   Taniguchi, Hirokazu ^a   Iwanari, Hiroko ^b   Yashiro, Masakazu ^c   Hirakawa, Kosei ^c   Kodama, Tatsuhiko ^a   Aburatani, Hiroyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Perseus Proteomics   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARRIER PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEASOME; PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; WWOX PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL FRACTIONATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE; GENE DELETION; GENE MUTATION; GENETICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LEYDIG CELL; MAMMARY GLAND; METABOLISM; MITOCHONDRION; MOUSE; MOUSE STRAIN; NUCLEAR LOCALIZATION SIGNAL; OVARY FOLLICLE CELL; PHYSIOLOGY; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RNA TRANSCRIPTION; STAINING; STOMACH CARCINOMA; STOMACH TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WWOX GENE;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; SUBCELLULAR FRACTIONS;

EID: 0346059608     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sutherland, G. R., Baker, E., and Richards, R. I. Fragile sites still breaking. Trends Genet., 14: 501-506, 1998.
2. , Suzuki, H., Komiya, A., Emi, M., Kuramochi, H., Shiraishi, T., Yatani, R., and Shimazaki, J. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer. 17: 225-233, 1996.
3. Driouch, K., Dorion-Bonnet, F., Briffod, M., Champeme, M. H., Longy, M., and Lidereau, R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer, 19: 185-191, 1997.
4. Chen, T., Sahin, A., and Aldaz, C. M. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res., 56: 5605-5609, 1996.
5. Li, C., Berx, G., Larsson, C., Auer, G., Aspenblad, U., Pan, Y., Sundelin, B., Ekman, P., Nordenskjold, M., van Roy, F., and Bergerheim, U. S. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes Cancer, 24: 175-182, 1999.
6. Paige, A. J., Taylor, K. J., Stewart, A., Sgouros, J. G., Gabra, H., Sellar, G. C., Smyth, J. F., Porteous, D. J., and Watson, J. E. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res., 60: 1690-1697, 2000.
7. Krummel, K. A., Roberts, L. R., Kawakami, M., Glover, T. W., and Smith, D. I. The characterization of the common fragile site FRA 16D and its involvement in multiple myeloma translocations. Genomics. 69: 37-46, 2000.
8. Mashimo, T., Watabe, M., Cuthbert, A. P., Newbold, R. F., Rinker-Schaeffer, C. W., Helfer, E., and Watabe, K. Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res., 58: 4572-4576, 1998.
9. Bednarek, A. K., Laflin, K. J., Daniel, R. L., Liao. Q., Hawkins, K. A., and Aldaz, C. M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res., 60: 2140-2145, 2000.
10. Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J. K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D., Baker, E., and Richards, R. I. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet., 9: 1651-1663, 2000.
11. Chang, N. S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G. B., and Zevotek, N. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J. Biol. Chem., 276: 3361-3370, 2001.
12. Paige, A. J., Taylor, K. J., Taylor, C., Hillier, S. G., Farrington, S., Scott, D., Porteous, D. J., Smyth, J. F., Gabra, H., and Watson, J. E. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc. Natl. Acad. Sci. USA, 98: 11417-11422, 2001.
13. Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R., and Frengen, E. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21: 1832-1840, 2002.
14. Kuroki, T., Trapasso, F., Shiraishi, T., Alder, H., Mimori, K., Mori, M., and Croce, C. M. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res., 62: 2258-2260, 2002.
15. Yakicier, M. C., Legoix, P., Vaury, C., Gressin, L., Tubacher, E., Capron, F., Bayer, J., Degott, C., Balabaud, C., and Zucman-Rossi, J. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene, 20: 5232-5238, 2001.
16. Yendamuri, S., Kuroki, T., Trapasso, F., Henry, A. C., Dumon, K. R., Huebner, K., Williams, N. N., Kaiser, L. R., and Croce, C. M. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res., 63: 878-881, 2003.
17. Bednarek, A. K., Keck-Waggoner, C. L., Daniel, R. L., Laflin, K. J., Bergsagel, P. L., Kiguchi, K., Brenner, A. J., and Aldaz, C. M. WWOX. the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res., 61: 8068-8073, 2001.
18. Yashiro, M., Chung, Y. S., Nishimura, S., Inoue, T., and Sowa, M. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin. Exp. Metastasis, 14: 43-54, 1996.
19. Fujihara, T., Sawada, T., Hirakawa, K., Chung, Y. S., Yashiro, M., Inoue, T., and Sowa, M. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin. Exp. Metastasis, 16: 389-398, 1998.
20. Hippo, Y., Yashiro, M., Ishii, M., Taniguchi, H., Tsutsumi, S., Hirakawa, K., Kodama, T., and Aburatani, H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res., 61: 889-895, 2001.
21. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
22. Chang, N. S., Doherty, J., and Ensign, A. JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J. Biol. Chem., 278: 9195-9202, 2003.